Catherine Ryan
Catherine is working as a Research Assistant in the Nanobodies Discovery team. She graduated with an Integrated Masters in Biomedical Science from the University of Birmingham in 2026, with her research project focusing on training a deep-learning-based model to help screen drugs for childhood-onset neurodegeneration. Before her final year of university, she completed an internship at Lightcast Discovery in the Antibody Discovery & Assay Development team.
Nanobodies Discovery Platform
Nanobodies are single domain antibodies derived from the unique heavy chain only immunoglobulins of camels, llamas, and alpacas.
Nanobody-guided antivirus drug delivery
The threat of emerging new viruses is rising, demanding more effective antiviral strategies to block progression of acute infections. A fast-acting new treatment could reduce the need for intensive care for people most at risk.